GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Cash Flow-to-Debt Ratio
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of Rs362.20 Million could theoretically repay 0% of its total liabilities (Rs17.31 Billion) in one year. Explore long-term investment intensity of GlaxoSmithKline Pharmaceuticals Limited to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlaxoSmithKline Pharmaceuticals Limited Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Also explore total assets of GlaxoSmithKline Pharmaceuticals Limited for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year debt coverage analysis for GlaxoSmithKline Pharmaceuticals Limited. For market capitalisation and broader financial context, see GlaxoSmithKline Pharmaceuticals Limited market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.60x | Rs12.90 Billion | Rs21.57 Billion | ▲ +82.8% |
| 2024 | 0.33x | Rs5.82 Billion | Rs17.79 Billion | ▲ +7.1% |
| 2023 | 0.31x | Rs4.84 Billion | Rs15.85 Billion | ▼ -25.8% |
| 2022 | 0.41x | Rs8.11 Billion | Rs19.70 Billion | ▲ +14.9% |
| 2021 | 0.36x | Rs5.78 Billion | Rs16.14 Billion | ▼ -4.0% |
| 2020 | 0.37x | Rs4.90 Billion | Rs13.15 Billion | ▲ +65.5% |
| 2019 | 0.23x | Rs3.99 Billion | Rs17.71 Billion | ▼ -9.9% |
| 2018 | 0.25x | Rs4.73 Billion | Rs18.90 Billion | ▲ +5.7% |
| 2017 | 0.24x | Rs2.36 Billion | Rs9.97 Billion | ▲ +129.6% |
| 2016 | 0.10x | Rs1.39 Billion | Rs13.50 Billion | ▼ -70.2% |
| 2015 | 0.35x | Rs2.70 Billion | Rs7.80 Billion | ▲ +40.2% |
| 2014 | 0.25x | Rs2.81 Billion | Rs11.40 Billion | ▼ -14.9% |
| 2013 | 0.29x | Rs3.14 Billion | Rs10.82 Billion | ▼ -2.4% |
| 2012 | 0.30x | Rs3.36 Billion | Rs11.30 Billion | ▼ -46.8% |
| 2011 | 0.56x | Rs4.79 Billion | Rs8.59 Billion | ▼ -22.3% |
| 2010 | 0.72x | Rs5.12 Billion | Rs7.12 Billion | ▲ +62.2% |
| 2009 | 0.44x | Rs3.30 Billion | Rs7.45 Billion | ▼ -9.0% |
| 2008 | 0.49x | Rs3.19 Billion | Rs6.55 Billion | ▲ +10.0% |
| 2007 | 0.44x | Rs2.59 Billion | Rs5.84 Billion | ▼ -28.7% |
| 2006 | 0.62x | Rs3.49 Billion | Rs5.63 Billion | ▲ +32.9% |
| 2005 | 0.47x | Rs2.29 Billion | Rs4.90 Billion | — |